Physician profile
Steve Simpson
NPI 1225141427
$630.50
in general payments reported to CMS, 2019-2025
6 companies · $26.30 in 2025
The $26.30 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2021: $141 · 2022: $224 · 2025: $26.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $324.06 | 2019-2022 | |
| Global Blood Therapeutics, INC. | $125.00 | 2022 | |
| Acell, INC. | $108.45 | 2019 | |
| Pfizer INC. | $30.78 | 2019 | |
| Abiomed | $26.30 | 2025 | |
| Sanofi Pasteur INC. | $15.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.